Alizyme News.11 Dec 2005 09:29
The news will be the results of the European Trials of "Celilistat". With the potential wealth of this drug being well into the billions and of course Alizymes other three drugs, inc. "Renzapride" (irritable bowel), well down the line the company has a great potential. The Chairman, Sir Brian Richards, plays his cards near to his chest, and with his feet well on the ground, he won't go for the "glory run". The potential of this company is very high. It has money for a year or two so it is well set up. Take over? Well the big companies must have it in view! All these shares are risky but this one is less risky than most.